Cargando…
FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
Fluorouracil (5-FU) is the first-line chemotherapeutic drug for cholangiocarcinoma (CCA), but its efficacy has been compromised by the development of resistance. Development of 5-FU resistance is associated with elevated expression of its cellular target, thymidylate synthase (TYMS). E2F1 transcript...
Autores principales: | Intuyod, Kitti, Saavedra-García, Paula, Zona, Stefania, Lai, Chun-Fui, Jiramongkol, Yannasittha, Vaeteewoottacharn, Kulthida, Pairojkul, Chawalit, Yao, Shang, Yong, Jay-Sze, Trakansuebkul, Sasanan, Waraasawapati, Sakda, Luvira, Vor, Wongkham, Sopit, Pinlaor, Somchai, Lam, Eric W.-F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6290025/ https://www.ncbi.nlm.nih.gov/pubmed/30538221 http://dx.doi.org/10.1038/s41419-018-1235-0 |
Ejemplares similares
-
Retraction Note to: FOXM1 modulates 5-fluorouracil sensitivity in cholangiocarcinoma through thymidylate synthase (TYMS): implications of FOXM1–TYMS axis uncoupling in 5-FU resistance
por: Intuyod, Kitti, et al.
Publicado: (2021) -
FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma
por: Wang, Liang, et al.
Publicado: (2022) -
FOXM1c is the predominant FOXM1 isoform expressed in cholangiocarcinoma that associated with metastatic potential and poor prognosis of patients
por: Klinhom-on, Nathakan, et al.
Publicado: (2021) -
Attenuation of CD47-SIRPα Signal in Cholangiocarcinoma Potentiates Tumor-Associated Macrophage-Mediated Phagocytosis and Suppresses Intrahepatic Metastasis()()
por: Vaeteewoottacharn, Kulthida, et al.
Publicado: (2018) -
Correction: FOXM1-induced TYMS upregulation promotes the progression of hepatocellular carcinoma
por: Wang, Liang, et al.
Publicado: (2022)